Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Natasha Dubois-Cauwelaert"'
Autor:
Simon Valayer, Marie Alexandre, Mélanie Prague, Abdoul Habib Beavogui, Seydou Doumbia, Mark Kieh, Brian Greenwood, Bailah Leigh, Marie Poupelin, Christine Schwimmer, Samba O. Sow, Irina Maljkovic Berry, Jens H. Kuhn, Daniela Fusco, Natasha Dubois Cauwelaert, Deborah Watson-Jones, Rodolphe Thiébaut, Yves Lévy, Yazdan Yazdanpanah, Laura Richert, Edouard Lhomme
Publikováno v:
Emerging Microbes and Infections (2024)
rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo are WHO-prequalified vaccination regimens against Ebola virus disease (EVD). Challenges associated with measuring long-term clinical protection warrant the evaluation of immune response kinetics after vacc
Externí odkaz:
https://doaj.org/article/0c49f2fb9f8e48d4b0939a6c4f0d61bb
Autor:
Benoit Garin, Innocente Djaomazala, Natasha Dubois-Cauwelaert, Vaomalala Raharimanga, Fidiarivony Ralison, Perlinot Herindrainy, Nivosoa C. Andriamalala, Derek Sarovich, Mark Mayo, Mirjam Kaestli, Bart J. Currie
Publikováno v:
Emerging Infectious Diseases, Vol 20, Iss 10, Pp 1735-1737 (2014)
Melioidosis is an often fatal infectious disease affecting humans and animals in the tropics. Only sporadic cases have been reported from Africa and the Indian Ocean region. We describe 2 confirmed autochthonous cases of human melioidosis in Madagasc
Externí odkaz:
https://doaj.org/article/deeeb53d477a49f4b227bbd83cb5011c
Autor:
Sasha E. Larsen, Susan L. Baldwin, Mark T. Orr, Valerie A. Reese, Tiffany Pecor, Brian Granger, Natasha Dubois Cauwelaert, Brendan K. Podell, Rhea N. Coler
Publikováno v:
Vaccines, Vol 6, Iss 2, p 30 (2018)
It is estimated that one third of the world’s population is infected with Mycobacterium tuberculosis (Mtb). This astounding statistic, in combination with costly and lengthy treatment regimens make the development of therapeutic vaccines paramount
Externí odkaz:
https://doaj.org/article/1bd3c591d0f5443787e2a0d1fccfca66
Autor:
Sasha E Larsen, Natasha Dubois Cauwelaert, Rhea N. Coler, Jesse H. Erasmus, Neal Van Hoeven, Mark T. Orr, Emily Gage
Publikováno v:
European Journal of Immunology. 49:266-276
Influenza A annually infects 5-10% of the world's human population resulting in one million deaths. Influenza causes annual epidemics and reinfects previously exposed individuals because of antigenic drift in the glycoprotein hemagglutinin. Due to an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b7d19b713a8d732ed9ad60cfe40f5ae
https://doi.org/10.1002/eji.201847852
https://doi.org/10.1002/eji.201847852
Autor:
Anthony L. Desbien, Darrick Carter, Christopher B. Fox, Hilton R. Bailor, Steven G. Reed, Hong Liang, Mark T. Orr, Malcolm S. Duthie, Steven J. Reed, Natasha Dubois Cauwelaert
Publikováno v:
The Journal of Immunology. 197:4351-4359
Designing modern vaccine adjuvants depends on understanding the cellular and molecular events that connect innate and adaptive immune responses. The synthetic TLR4 agonist glycopyranosyl lipid adjuvant (GLA) formulated in a squalene-in-water emulsion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::936cea7ebea32e5ee93976fb473b9d2d
https://doi.org/10.4049/jimmunol.1600993
https://doi.org/10.4049/jimmunol.1600993
Autor:
Susan L. Baldwin, Anthony L. Desbien, Emily Gage, Mark T. Orr, Natasha Dubois Cauwelaert, Rhea N. Coler, Kimberly A. Hofmeyer
Publikováno v:
European Journal of Immunology. 46:2719-2729
The contribution of B cells to immunity against many infectious diseases is unquestionably important and well characterized. Here, we sought to determine the role of B cells in the induction of T helper 1 (TH1) CD4+ T cells upon vaccination with a tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4efcf64c465c44302b731878470db898
https://doi.org/10.1002/eji.201646399
https://doi.org/10.1002/eji.201646399
Autor:
Christopher B. Fox, Quinton M. Dowling, Michelle Archer, Dawn M. Fedor, Po-Wei D. Huang, Alicia M. Schwartz, Natasha Dubois Cauwelaert, Thomas S. Vedvick, Elyse A. Beebe, Mark T. Orr, Ryan M. Kramer
Publikováno v:
International Journal of Nanomedicine
Ryan M Kramer, Michelle C Archer, Mark T Orr, Natasha Dubois Cauwelaert, Elyse A Beebe, Po-wei D Huang, Quinton M Dowling, Alicia M Schwartz, Dawn M Fedor, Thomas S Vedvick, Christopher B Fox Infectious Disease Research Institute, Seattle, WA, USA Ba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd4fba7f06d2f51415408295b031d995
https://pubmed.ncbi.nlm.nih.gov/29983563
https://pubmed.ncbi.nlm.nih.gov/29983563
Autor:
Valerie A. Reese, Susan L. Baldwin, Tiffany Pecor, Brendan K. Podell, Natasha Dubois Cauwelaert, Mark T. Orr, Rhea N. Coler, Sasha E Larsen, Brian Granger
Publikováno v:
Vaccines, Vol 6, Iss 2, p 30 (2018)
Vaccines
Vaccines; Volume 6; Issue 2; Pages: 30
Vaccines
Vaccines; Volume 6; Issue 2; Pages: 30
It is estimated that one third of the world’s population is infected with Mycobacterium tuberculosis (Mtb). This astounding statistic, in combination with costly and lengthy treatment regimens make the development of therapeutic vaccines paramount
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79689bbc60e6d8399ace492527bf999f
http://www.mdpi.com/2076-393X/6/2/30
http://www.mdpi.com/2076-393X/6/2/30
Autor:
Natasha Dubois Cauwelaert, Christopher B. Fox, Mark T. Orr, Darrick Carter, Nicholas D. Rintala, Ryan M. Kramer, Hong Liang, Emilie Seydoux, Michelle Archer
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 201(1)
The involvement of innate receptors that recognize pathogen- and danger-associated molecular patterns is critical to programming an effective adaptive immune response to vaccination. The synthetic TLR4 agonist glucopyranosyl lipid adjuvant (GLA) syne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a286c755810f940e817bb2b0f75b6519
https://pubmed.ncbi.nlm.nih.gov/29769270
https://pubmed.ncbi.nlm.nih.gov/29769270
Autor:
Christopher B. Fox, Steven J. Reed, Anthony L. Desbien, Natasha Dubois Cauwelaert, Darrick Carter, Steven G. Reed, Hilton R. Bailor, Malcolm S. Duthie, Mark T. Orr, John D. Laurance
Publikováno v:
European Journal of Immunology. 45:407-417
The synthetic TLR4 agonist glucopyranosyl lipid adjuvant (GLA) is a potent Th1-response-inducing adjuvant when formulated in a squalene oil-in-water emulsion (SE). While the innate signals triggered by TLR4 engagement are well studied, the contributi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea0f315770c5ebc2378b3012c7bf4c92
https://doi.org/10.1002/eji.201444543
https://doi.org/10.1002/eji.201444543